Unusual Options Activity Insight: Moderna
Shares of Moderna (NASDAQ:MRNA) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $315.35.
Moderna Debuts In S&P 500, Institutions Buy Billions Worth Of Stock
Wednesday morning marked the inclusion of Moderna, Inc (NASDAQ: MRNA) in the S&P 500.
Alzheimer’s Approval, COVID-19 Vaccines Put Spotlight On Biotech Sector, But What’s Next?
For most of the past year, just a handful of companies carried the biotech sector, thanks to their quick responses to the COVID-19 pandemic.
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 20)
Moderna Joins AMC, Nvidia, GameStop Among Top WallStreetBets Interests
Moderna Inc. (NASDAQ: MRNA) has joined AMC Entertainment Holdings Inc. (NYSE: AMC) and Nvidia Corp. (NASDAQ: NVDA) as the stocks seei
PreMarket Prep Stock Of The Day: Pfizer
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.
Unusual Options Activity Insight: Moderna
Shares of Moderna (NASDAQ:MRNA) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved down to $310.46.
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday morning, 54 companies achieved new highs for the year.
Moderna Extends Rally With Expanded Japanese COVID-19 Vaccine Supply Deal
Moderna, Inc. (NASDAQ: MRNA) shares appear to be going from strength to strength, and the premarket price action Tuesday suggests a positive open for the fifth straight session.